IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Call: Horizon Pharma PLC NOV 22 EXP 11/16/18

CUSIP: G4617B40K | 1 institutional holders

Quarters

Q3 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile